Home
Conditions
Pulmonary Eosinophilia

Clinical trial condition

Pulmonary Eosinophilia

Explore clinical trials studying Pulmonary Eosinophilia. Study availability and eligibility vary by location and protocol.

72 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Eosinophilia trial results

Active, not recruiting

Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI

NCT03733535

Conditions: Asthma; Eosinophilic, Eosinophilia, Hematologic Diseases, +6 more
Locations: Robarts Research Institute; The University of Western Ontario; London Health Sciences Centre London, Ontario, Canada

View Trial Details

Active, not recruiting

A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT05942222

Conditions: Asthma; Eosinophilic, Chronic Rhinosinusitis With Nasal Polyps, Eosinophilia, +7 more
Locations: Aalborg Universitetssygehus Syd Aalborg, Denmark

Aarhus Universitetshospital Skejby Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Sydvestjysk Sygehus Esbjerg Esbjerg, Denmark

View Trial Details

Active, not recruiting

The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma

NCT05144087

Conditions: Asthma, Asthma; Eosinophilic, Bronchial Diseases, +13 more
Locations: NIHR Clinical Research Facility Southampton, Hampshire, United Kingdom

View Trial Details

Completed

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

NCT06465485

Conditions: Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Research Site Beijing, China

Research Site Beijing, China

Research Site Beijing, China

Research Site Beijing, China

View all 74 locations

View Trial Details

Completed

Severe Asthma, MepolizumaB and Affect: SAMBA Study

NCT04680611

Conditions: Adjustment, Adjustment, Emotional, Anxiety, +27 more
Locations: Department of Respiratory Medicine, Aberdeen Royal Infirmary Aberdeen, Grampian, United Kingdom

Judit Varkonyi-Sepp Southampton, Hampshire, United Kingdom

Hull University Teaching Hospitals NHS Trust Hull, Yorkshire, United Kingdom

Pinderfields Hospital Wakefield, Yorkshire, United Kingdom

View Trial Details

Completed

Eosinophils Endotypes in Chronic Airway Inflammatory Diseases

NCT04187976

Conditions: Asthma, Bronchial Diseases, Chronic Sinusitis, +15 more
Locations: CHU Lille Lille, France

View Trial Details

Completed

A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

NCT05440656

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations: Research Site Alexandroupoli, Greece

Research Site Athens, Greece

Research Site Athens, Greece

Research Site Athens, Greece

View all 13 locations

View Trial Details

Completed

Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

NCT05002621

Conditions: Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

NCT05603845

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations: Research Site Bogotá, Colombia

Research Site Bucaramanga, Colombia

Research Site Ibague, Colombia

Research Site Pereira, Colombia

View all 24 locations

View Trial Details

Completed

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

NCT05091385

Conditions: Asthma; Eosinophilic, Eosinophilia, Hematologic Diseases, +6 more
Locations: Medical University of Lodz, Dept. of Immunology and Allergy Lodz, Poland

View Trial Details

Pulmonary Eosinophilia

Pulmonary Eosinophilia trial results

Related conditions